Kraig Biocraft featured on National Geographic cover

Kraig Biocraft Laboratories, Inc. disclosed that it has been featured in a cover article of the March 2026 issue of National Geographic.

Rhea-AI Filing Summary

Kraig Biocraft Laboratories, Inc. disclosed that it has been featured in a cover article of the March 2026 issue of National Geographic. The company notes that this March 2026 issue is currently available only in select markets and is expected to be distributed nationally in the coming weeks.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Kraig Biocraft Laboratories (KBLB) announce in its latest disclosure?

Kraig Biocraft Laboratories announced it is featured in a cover article of the March 2026 issue of National Geographic. The company highlighted this media exposure as a notable event for its business profile and public visibility.

Which National Geographic issue features Kraig Biocraft Laboratories (KBLB)?

Kraig Biocraft Laboratories is featured in a cover article of the March 2026 issue of National Geographic. This specific issue is mentioned by the company as an important media appearance tied to its operations and technology.

Is the National Geographic issue featuring Kraig Biocraft Laboratories (KBLB) widely available yet?

The March 2026 National Geographic issue featuring Kraig Biocraft Laboratories is currently available only in select markets. The company states it is expected to be distributed nationally in the coming weeks as circulation expands.

Why is the National Geographic feature relevant for Kraig Biocraft Laboratories (KBLB) investors?

The National Geographic cover feature gives Kraig Biocraft Laboratories broader public exposure. Such media attention can raise awareness of the company’s technology and brand, potentially supporting its reputation even though no direct financial impact is detailed.

Who signed the recent Kraig Biocraft Laboratories (KBLB) disclosure about the National Geographic feature?

The disclosure was signed on behalf of Kraig Biocraft Laboratories by Kim Thompson. Thompson is identified as the company’s Chief Executive Officer, Chief Financial Officer, and Director, underscoring executive-level authorization of the announcement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 11:17 AM EST Learn about SEC filing dates

false 0001413119 0001413119 2026-02-18 2026-02-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 18, 2026

KRAIG BIOCRAFT LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

Wyoming		333-146316		83-0458707
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

2723 South State St. Suite 150

Ann Arbor, Michigan 48104
(Address of principal executive offices, including Zip Code)

(734) 619-8066

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		-		-

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

Kraig Biocraft Laboratories, Inc. has been featured in a cover article of the March 2026 issue of National Geographic. The March 2026 issue is currently only available in select markets but is expected to be distributed nationally in the coming weeks.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 18, 2026

	KRAIG BIOCRAFT LABORATORIES, INC.
	By:	/s/ Kim Thompson
		Kim Thompson
		Chief Executive Officer, Chief Financial Officer and Director

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 2.9 KB
• EX-101 XBRL LABEL FILE 34.1 KB
• EX-101 XBRL PRESENTATION FILE 22.3 KB